NDC properties for "tinidazole 250 MG Oral Tablet" (RxCUI 477234)
About this data
The tables show NDC propoerties for tinidazole 250 MG Oral Tablet with the RxCUI 477234
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tinidazole 250 MG Oral Tablet (RxCUI 477234)
| ANDA | ANDA202044 |
|---|---|
| ANDA | ANDA202489 |
| ANDA | ANDA203808 |
| MMSL_CODE | BD12421 |
| MMSL_CODE | CD12421 |
| RxCUI | 477234 |
| SNOMEDCT | 412336009 |
| SPL_SET_ID | 32167dd7-5d37-457b-9b00-cd735de6b060 |
| SPL_SET_ID | 4e03b4ac-c88a-4044-9d58-0cfcda3db53c |
| SPL_SET_ID | 6f3ce597-64c1-4204-a67a-8b6f6e7e8bca |
| SPL_SET_ID | 95ab57b2-5d7e-4986-abcd-65edf1728383 |
| SPL_SET_ID | b39bc167-f1c4-4169-8b46-e6c2eafe6bbf |
| VUID | 4017103 |
| Prescribable Synonym | tinidazole 250 MG Oral Tablet |
| RXNAV_STR | tinidazole 250 MG Oral Tablet |
| RxNorm Name | tinidazole 250 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 477234) |
NDC Properties
NDC Item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0054-0347 |
NDC Item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 16571-214 |
NDC Item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| Packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42799-207 |
NDC Item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| Packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 43386-550 |
NDC Item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 62135-834 |
NDC Item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 64980-426 |
NDC Item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0054-0347 |
NDC Item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 16571-214 |
NDC Item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| Packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42799-207 |
NDC Item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| Packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 43386-550 |
NDC Item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 62135-834 |
NDC Item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 64980-426 |
NDC Item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0054-0347 |
NDC Item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 16571-214 |
NDC Item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| Packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42799-207 |
NDC Item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| Packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 43386-550 |
NDC Item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 62135-834 |
NDC Item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 64980-426 |
NDC Item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0054-0347 |
NDC Item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 16571-214 |
NDC Item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| Packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42799-207 |
NDC Item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| Packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 43386-550 |
NDC Item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 62135-834 |
NDC Item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 64980-426 |
NDC Item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0054-0347 |
NDC Item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 16571-214 |
NDC Item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| Packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42799-207 |
NDC Item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| Packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 43386-550 |
NDC Item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 62135-834 |
NDC Item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 64980-426 |
NDC Item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0054-0347 |
NDC Item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| Packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 16571-214 |
NDC Item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| Packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42799-207 |
NDC Item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| Packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 43386-550 |
NDC Item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 62135-834 |
NDC Item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| Packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 64980-426 |